EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62021TN0006
Case T-6/21: Action brought on 7 January 2021 — Advanced Organic Materials v EUIPO — Swiss Pharma International (ADVASTEROL)
Case T-6/21: Action brought on 7 January 2021 — Advanced Organic Materials v EUIPO — Swiss Pharma International (ADVASTEROL)
Case T-6/21: Action brought on 7 January 2021 — Advanced Organic Materials v EUIPO — Swiss Pharma International (ADVASTEROL)
OJ C 62, 22.2.2021, p. 47–48
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
22.2.2021 |
EN |
Official Journal of the European Union |
C 62/47 |
Action brought on 7 January 2021 — Advanced Organic Materials v EUIPO — Swiss Pharma International (ADVASTEROL)
(Case T-6/21)
(2021/C 62/59)
Language in which the application was lodged: Spanish
Parties
Applicant: Advanced Organic Materials, SA (Pilar, Argentina) (represented by: J.L. Rivas Zurdo, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Swiss Pharma International AG (Zurich, Switzerland)
Details of the proceedings before EUIPO
Applicant for the trade mark at issue: Defendant before the General Court
Trade mark at issue: Application for European Union word mark ADVASTEROL — Application for registration No 14 525 521
Proceedings before the EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 27 October 2020 in Case R 781/2019-4
Form of order sought
The applicant claims that the General Court should:
— |
annul the contested decision in so far as, by dismissing the appeal of Advanced Organic Materials, SA, it upholds the decision of the Opposition Division, which partially upheld opposition B 2 624 370, refusing some of the goods covered by European Union trade mark No 14 525 521 ADVASTEROL (word mark); |
— |
order the opposing party or parties to pay the costs. |
Plea in law
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.